SEZARY SYNDROME
Clinical trials for SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare skin cancer: safer chemo combo enters human trials
Disease control Not yet recruitingThis study tests a new combination of drugs (CAOP) for people with cutaneous T-cell lymphoma (CTCL) that has come back or not responded to prior treatment. The goal is to find the safest dose and see if the treatment shrinks tumors. About 37 adults aged 60 and older will take par…
Matched conditions: SEZARY SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New antibody targets Hard-to-Treat skin cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new drug, DT-7012, for people with advanced cutaneous T-cell lymphoma (CTCL) that has not responded to other treatments. The drug is an antibody designed to seek out and destroy cancer cells in the skin while also helping the immune system fight the…
Matched conditions: SEZARY SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Rare skin disease mystery: could immune cells explain lymphoma risk?
Knowledge-focused Not yet recruitingThis study looks at the immune cells in the blood of 10 adults with a rare genetic skin condition called NIPAL4 ichthyosis. Researchers want to see if these cells are different from normal, because three people with this skin disease also developed a rare lymphoma. The goal is to…
Matched conditions: SEZARY SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 08:16 UTC